2013
DOI: 10.1016/j.oraloncology.2013.02.011
|View full text |Cite
|
Sign up to set email alerts
|

Nutraceuticals as new treatment approaches for oral cancer: II. Green tea extracts and resveratrol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(19 citation statements)
references
References 51 publications
0
19
0
Order By: Relevance
“…Therefore, EGCG and TF would be perfect candidates for this type of treatment. Despite the enormous number of studies done on cancer therapy using EGCG [20, 2426] or TF [17, 27, 28], surprisingly there are no reports on the synergistic effects of these polyphenols on cancer cells. In our research we chose the concentration of 20 μg/ml for both polyphenols as this concentration had a weak anticancer effect for both compounds individually.…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, EGCG and TF would be perfect candidates for this type of treatment. Despite the enormous number of studies done on cancer therapy using EGCG [20, 2426] or TF [17, 27, 28], surprisingly there are no reports on the synergistic effects of these polyphenols on cancer cells. In our research we chose the concentration of 20 μg/ml for both polyphenols as this concentration had a weak anticancer effect for both compounds individually.…”
Section: Resultsmentioning
confidence: 99%
“…It is obtained from the non-fermented leaves of the Camellia sinensis plant. It has promising health beneficial effects and it is considered as one of the most important nutraceuticals that used as new treatment approaches for oral cancer [48]. The polyphenols of GT (GTP), particularly catechin ( −) epigallocatechin-3-gallate (EGCG), which has about 50-80% of the total catechins in GT, is reported to have an antioxidant effect [49].…”
Section: Green Tea-drug Interactionmentioning
confidence: 99%
“…Similar to CUR, RES may have partial biological activity due to poor absorption and first-pass metabolism [ 16 , 17 ]. It has been reported that RES and CUR inhibit the growth of HNSCC cell lines when employed as single drugs [ 18 - 25 ]. Overall, the poor bioavailability of CUR and RES will affect the effective dose delivered to cancer cells.…”
Section: Introductionmentioning
confidence: 99%